First Citizens Financial Corp Nymox Pharmaceutical Corp Transaction History

First Citizens Financial Corp

  • $168 Million
  • Q1 2024

A detailed history of First Citizens Financial Corp transactions in Nymox Pharmaceutical Corp stock. As of the latest transaction made, First Citizens Financial Corp holds 35,100 shares of NYMX stock, worth $16,497. This represents 0.01% of its overall portfolio holdings.

Number of Shares
35,100
Previous 35,100 -0.0%
Holding current value
$16,497
Previous $16,000 -0.0%
% of portfolio
0.01%
Previous 0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

Apr 27, 2020
BUY
$1.69 - $3.88 $59,319 - $136,188
35,100 New
35,100 $82,000

Others Institutions Holding NYMX

# of Institutions
6
Shares Held
150K
Call Options Held
0
Put Options Held
0
View Full List

About NYMOX PHARMACEUTICAL CORP

NYMX Quotes by TradingView
  • Ticker NYMX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 91,265,000
  • Market Cap $42.9M
  • Description
  • Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population in Canada, the United States, Europe, and internationally. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which has completed Phase III clinical trials for the treatment of benign prostatic hyperpl...
More about NYMX
Track This Portfolio

Track First Citizens Financial Corp Portfolio

Follow First Citizens Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Citizens Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on First Citizens Financial Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email